CO-DIAGNOSTICS, INC. (CODX) Return on equity 2017–2025
CO-DIAGNOSTICS, INC. (CODX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-227.3%FY2025 · since FY2017: -180.7% → -227.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -227.3% | -157.5 pp |
| FY2024 | -69.9% | -28.6 pp |
| FY2023 | -41.3% | -28.9 pp |
| FY2022 | -12.4% | -39.7 pp |
| FY2021 | 27.3% | -36.4 pp |
| FY2020 | 63.7% | +420.3 pp |
| FY2019 | -356.6% | — |
| FY2017 | -180.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net incomeCODX Net marginCODX Gross profitCODX Gross marginCODX Operating incomeCODX Operating marginCODX Operating cash flowCODX Free cash flowCODX Capital expendituresCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Total liabilitiesCODX Shareholders’ equityCODX overview →